Search Index

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link What does depression do to your brain? 18/03/25, 12:07 Last updated: Published: 10/10/24, 11:19 Also known as Major Depressive Disorder (MDD) This is Article 1 in a series on psychiatric disorders and the brain. Next article coming soon. -- I affect 3.8% of the population wide, With 280 million voices struggling inside. In women, my reach is 6%, And 5.7% of those over 60 feel me. Among new mothers, I reach 10%, With over 700,000 lost to my torment each year. What am I? Depression. The most prevalent psychiatric disorder that costs both money and lives. -- Also known as Major Depressive Disorder (MDD), depression is a heterogenous disease, which means the manifestation of the disorder is influenced by multiple genes. It is commonly known that consistent low mood, loss of interest in hobbies you used to enjoy, lethargy, feeling of hopelessness etc. are physical symptoms of depression. However, have you ever wondered what happens in the brain in a depression sufferer, from the neuroscience aspect? Structurally, research into the neuroscience of depression reveals significant structural abnormalities in the brains of affected individuals. Studies using structural magnetic resonance imaging (MRI) have shown that those with MDD show reductions in gray matter volume in regions responsible for emotion regulation. The limbic system of the brain is responsible for producing and regulating emotions. In depressed individuals, the hippocampus—a key component of the limbic system—shows reduced gray matter volume, which is linked to abnormalities in the associated white matter tracts. White matter consists of myelinated axons that facilitate communication between different brain regions, while grey matter contains the neuronal cell bodies responsible for processing information. The presence of abnormalities in white matter suggests a disconnection between regions within the limbic system, potentially impairing their ability to communicate effectively. This disconnection may contribute to the emotional dysregulation observed in depression, highlighting the intricate relationship between grey and white matter in the pathology of this disorder. Depression is a complex disorder that not only affects mood but changes the structure and function of the brain. By understanding the neurobiological changes—including reductions in grey matter and white matter disconnections—we can better grasp the pathogenesis of this condition. Continued research in the neuroscience behind depression is essential for developing more effective treatments. There is still much more to explore and understand in depression research; with each new discovery, we realise how much more there is to learn. Written by Chloe Kam Related article: Depression in children Project Gallery

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Are we doing enough to fight anti-fungal resistance? 05/12/24, 12:08 Last updated: Published: 04/11/24, 15:29 Antimicrobial Resistance (AMR) is a growing concern for healthcare systems globally Introduction to fungi Fungi are a fascinating yet relatively untouched area of microbiology. From growing in damp forest soil to the human body, these eukaryotes (surprisingly more closely related to animals than plants!) reproduce sexually and asexually, producing hyphae (long, branching filaments) to absorb nutrients. Even in the human body, fungal infections can range from athletes' foot to severe cases of invasive pneumonia. Despite its diverse and incredibly interesting nature, only 5% of all estimated fungal species worldwide have been discovered. There is a significant lack of knowledge regarding these amazing microorganisms. The challenge of antimicrobial resistance Antimicrobial Resistance (AMR) is a growing concern for healthcare systems globally. AMR is the process by which microbes develop decreased sensitivity to antimicrobial drugs, meaning they can evade drug and immune response, creating the potential for superbugs (i.e. Multi-Drug Resistant Staphylococcus Aureus/MRSA). An increasing number of resistant fungal species are emerging, with more than 90% of Candida Auris strains in the US now fluconazole resistant. Microorganisms can confer resistance in various ways, such as the misuse of antimicrobial drugs and pesticides in healthcare and agriculture or random genetic evolution (secondary vs primary resistance). Biofilm formation can also contribute to this, particularly for those with inserted medical devices. This can be seen in Candidiasis, for example on inserted catheters, as can be seen in Figure 2 . AMR was thought to be responsible for 1.27 million deaths globally in 2019, with an 8% increase in resistant infections in the UK from 2021-22. Global efforts regarding resistance appear to focus on antibiotic resistance, much reflective of worldwide research efforts. This leaves us wondering, are we doing enough to fight antifungal resistance? Mechanisms of fungal resistance Fungal infections, although typically mild, often present most severely in the immunocompromised, particularly those with cancer or who have had recent organ transplants. Invasive infections are cleared using five classes of antifungal drugs: azoles, polyenes, allylamines, flucytosine, and echinocandins, the two most common being azoles and echinocandins. Azoles aim to inhibit ergosterol synthesis, which is crucial for cell membrane stability, whilst echinocandins interfere with beta-1,3-D-glucan synthesis (a major component of fungal cell walls). Fungi can come in two forms: mould fungi (multicellular units containing branching hyphae), and yeast fungi (unicellular with the ability to ferment carbohydrates). In yeasts, azoles target the Erg11 protein (or Cyp51A for mould fungi), which disrupts ergosterol synthesis and causes the build up of 14a-methyl sterols. In turn, this disrupts membrane activity. Azole resistance can develop through different pathways: changes in the Erg11 amino acid structure, changes in Erg11 expression, and alterations to drug efflux pathways. For Candida species, amino acid substitutions occurring at the Erg11 enzyme binding site often lead to azole resistance, whilst in Aspergillus fumigatus, changes occur at codons 54-220 in Cyp51A. Resistant Candida albicans can also overexpress Erg11, meaning a higher drug concentration is needed to combat infection. Some fungal species, such as Candida spp. confer azole resistance by utilising drug efflux systems, particularly the ABC transporter MDR1, where a gain of function mutation can lead to multidrug resistance. Loss of heterozygosity, for example, by aneuploidy, can lead to resistance if this occurs across Erg11 or MDR1 gene loci. Inhibition of the Hsp90 pathway (a component of the cellular stress response) can alleviate both azole and echinocandin resistance and regulate biofilm resistance. Hsp90 stabilises the terminal MAPK component, increasing cell wall integrity (most antifungal drugs target the fungal cell wall). Global nature of AMR Global schemes have emerged to combat AMR, with fungal efforts appearing to lag behind its bacterial equivalent; The WHO published its first priority bacterial pathogens list in 2017, which has been effectively used by pharmaceutical companies, researchers, and local health trusts to target bacterial species, asserting themselves as an increasing risk. WHO Fungal Priority lists didn’t emerge until 2022, which was the first global effort to establish fungal species of risk. The One Health approach, another global strategy, aims to combat AMR by emphasising collaboration between multiple sectors, increasing innovation and creating clear communication. Its main aims lay in identifying knowledge gaps, involving policymakers, creating networks and sharing data. In addition to global strategies, national ones exist. The UK government made its own five year AMR-combatting plan, implementing a OneHealth approach; Previous plans have proven successful; antimicrobial exposure was reduced by 8%, with a further 81% reduction in antibiotic sales for food-producing mammals. It is clear AMR (particularly fungal resistance) is becoming an increasingly worrying issue. In 2019, UK deaths directly arising from drug resistant infections nearly matched those from stomach cancer, with an estimated further 35,000 deaths indirectly resulting from resistant infections. Hence, measures must be in place to contain its potential for worldwide damage. Insufficient action against AMR was predicted to have long-lasting effects like the COVID-19 pandemic every five years. Since drug-resistant fungi have the potential to cause significant burden on healthcare systems globally, what is currently being done to combat Fungal AMR? What more can we do? Fungal infections are the fifth leading cause of death worldwide, yet less than 1.5% of infectious disease funding goes towards research of fungal infections. This could be because fungal infections present mildly in most healthy people. However, we cannot ignore the fatal consequences for those with pre-existing illnesses or the devastating effects that could ensue if we do not make significant efforts to eliminate fungal resistance. In its most recent five-year plan, the UK government stated its support for initiatives to increase agrochemical stewardship, particularly focussing on fungicides. The efforts outlined include establishing a pharmaceutical monitoring programme, funding research into AMR-driving chemicals, and a pilot AMR surveillance scheme. This is significant progress, however, it focuses on environmental fungal resistance, with a tendency to ignore research efforts and failing to actively address fungi in most sections. To move forward, more efforts are needed to drive antifungal research - whether in expanding the number of antifungal classes available to patients or improving existing antifungal therapies (e.g. improvements in pharmacokinetics and efficacy). This is evidenced by the sheer number of antibiotics and respective classes compared to fungal counterparts; bacterial infections can be treated with a whopping two-fold more drug classes than their fungal equivalent. Moreover, the OneHealth approach emphasises the importance of diagnostics and testing; whilst most modern fungal testing methods are very sensitive and specific, some tests can only report positive results very late into disease progression (read more about OneHealth ). Hence, fungal diagnostic and testing approaches need to be optimised. This all can be achieved by pushing more funding towards fungal research and development, encouraged with government spending, and an emphasis on collaboration between academia and industry. How can we relay the importance of stewardship in agriculture, or bring more treatments to the bedside without collaboration and education? Written by Eloise Nelson Related article: The increasing threat of anti-microbial resistance REFERENCES Gaya E., Fungarium: Welcome to the Museum, 2019. Kundu R, Srinivasan R. Cytopathology of Fungal Infections. Current Fungal Infection Reports. 2021;15(3):81-92. The Role of Plant Agricultural Practices on Development of Antimicrobial Resistant Fungi Affecting Human Health: Proceedings of a Workshop Series.: Hearing before the National academies of Sciences, Engineering and Medicine (05.04.2023, 2023). Government U. Confronting antimicrobial resistance 2024 to 2029. In: Care DoHaS, editor. 2024. Fisher CM, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell ME, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology. 2022;20(9):557-71. Cowen EL, Sanglard D, Howard JS, Rogers DP, Perlin SD. Mechanisms of Antifungal Drug Resistance. Cold Spring Harbor Perspectives in Medicine. 2015;5(7):a019752. Fisher CM, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell ME, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology. 2022;20(9):557-71. WHO fungal priority pathogens list to guide research, development and public health action. WHO; 2022. Greener M. Why have we neglected fungal infections? Prescriber. 2022;33(8-9):20-3. Baker J, Denning WD. The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity. British Medical Bulletin. 2023;147(1):62-78. Project Gallery

When we think of bacteria, we tend to focus on their pathogenicity and ability to cause diseases such as tuberculosis, which infects around one-quarter of the world’s population. However, whilst bacteria do have the potential to become parasitic, if the trillions of bacterial cells that make up the human microbiome ceased to exist, human health would experience a rapid decline. Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Why bacteria are essential for human survival Last updated: 13/11/24 Published: 13/04/23 When we think of bacteria, we tend to focus on their pathogenicity and ability to cause diseases such as tuberculosis, which infects around one-quarter of the world’s population. However, whilst bacteria do have the potential to become parasitic, if the trillions of bacterial cells that make up the human microbiome ceased to exist, human health would experience a rapid decline. One reason for this is due to the critical role bacteria play in inducing the immune system against pathogenic threats. Upon viral infection, the interferon (IFN) defence system is initiated where the synthesis of antiviral cytokines is upregulated. Evidence suggests bacteria in the gut are capable of modulating the IFN system. They work by inducing macrophages and plasmacytoid dendritic cells to express type 1 IFN, which in turn primes natural killer cells and prepares cytotoxic CD8+ T cells for action. Erttmann et al (2022) demonstrate that a depletion of the gut microbiota diminishes the cell signalling pathways modulated by these commensal bacteria. This causes a reduction in type 1 IFN production, and thus an impairment in the activation of NK and CD8+ T cells. As a result, the body becomes more susceptible to attack by viral infections and less able to defend itself. This highlights just how vital the role bacteria in our microbiome play in providing us with innate immunity against viral pathogens and protecting our health. This also brings attention to our use of antibiotics, and the potential negative effects they may have on the commensal bacteria residing in our body. Erttmann et al (2022) further showed that mice treated with a variety of antibiotics exhibited a major reduction in gut microbiota diversity, thus severely comprising their ability to fight off viral infections. Research like this is important in informing doctors to be sensible in their administration of antibiotics, as well as informing patients to not self-medicate and unnecessarily ingest antibiotics. Ultimately, the commensal bacteria living in our bodies play essential roles in protecting human health, and it is, therefore, vital we take the necessary steps to also protect these remarkable microorganisms in return. Written by Bisma Butt Related article: The rising threat of antibiotic resistance REFERENCES Erttmann, S.F., Swacha, P., Aung, K.M., Brindefalk, B., Jiang, H., Härtlova, A., Uhlin, B.E., Wai, S.N. and Gekara, N.O., 2022. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity, 55(5), pp.847-861. Ganal, S.C., Sanos, S.L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S., Weiss, S., Staeheli, P., Aichele, P. and Diefenbach, A., 2012. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity, 37(1), pp.171-186.

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The story of pigments and dyes 17/02/25, 14:50 Last updated: Published: 20/11/23, 11:05 A chemist's palette Pigments and dyes are vital in producing vibrancy and changing colours in our surroundings. Their vast use in cosmetics, pharmaceuticals, inks and textiles makes them important in playing a crucial role in creating the colourful world we see around us. But how do they come into existence? It all started from the extraction of colours from the world around us, such as green chlorophyll found in leaves and reds from berries. They were used to decorate caves and clothes in early civilization. However, when synthetic dyes came into play in the 19th century, things took an advance. Mauveine was accidentally discovered by William Henry Perkin; its vivid purple colour proved that we could make complicated organic substances from simpler ones, challenging the idea that organic compounds could only come from living things or nature. How does chemistry relate to the colours produced? Well, the way molecules are built fundamentally decides what colours are visible. In summary, the colours we see are a result of electrons in atoms and molecules absorbing and then releasing energy in the form of light. The specific colours are determined by the amount of energy released and the unique arrangement of electrons in each substance. In chemistry, pigments and dyes are used in various applications such as indicators in chemical reactions, chromatography, photovoltaic cells and most commonly in titration. They enable researchers to explore chemical processes and analyse substances. However, there are many environmental concerns regarding synthetic dyes, with pollution and water contamination. Synthetic dyes may also contain chemicals and additives that are toxic to aquatic life, posing risks to the environment. To address these issues, regulations, research into eco-friendly alternatives, sustainable practices, and educating people on this is important. In essence, we are constantly reminded of the evolving relationship between colours and chemistry. In the future, as more materials change colours and new uses are discovered, chemists will continue to be fascinated by the endless possibilities. Written by Anam Ahmed Project Gallery

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link An end at the beginning: the tale of the Galápagos Tortoises 27/03/25, 11:19 Last updated: Published: 06/06/24, 11:20 Conservation efforts The Galápagos Islands Most who know of the name “Darwin” will be familiar with the Galápagos. These relatively uninviting islands protrude harsh, crashing waves like spears of mountainous rock, formed through millions of years of fierce volcanic activity. Even Charles Darwin himself thought life could not be sustained in such a remote and harsh environment, writing in his 1835 Journal of Researches: A broken field of basaltic lava, thrown into the most rugged waves, and crossed by great fissures, is everywhere covered by stunted, sun-burnt brushwood, which shows little signs of life. Little did the 22-year-old university graduate know at the time, these rugged islands would spark the most pivotal and influential theory in the field of modern biology. Due to the Hawaiian archipelago’s unique volcanic origins, the cluster of islands have grown jagged and fractured, with some islands showcasing altitudes as low as a few meters above sea level to others flexing spaces over 5000 feet above sea level. These extremely diverse habitats enable the observation of vastly different sub-populations of the same (or closely related) species*, exhibiting differing adaptations to their unique environments. These morphological distinctions lead to Darwin’s infamous 1859 book ‘On the Origin of Species’, detailing his evidence for the theories of evolution. *This article may refer to the Galápagos Tortoises as different subspecies or species interchanagably, as this remains a contentious area. The giant tortoises One most apparent examples of evolution that Darwin noted were the Galapagos tortoises, Chelonoidis niger , of which there were at least 15 subspecies. Darwin devoted almost four pages of his Journal of Researches to the Galapagos tortoise, more than he did to any other Galápagos species. These captivating reptiles can grow up to 5 feet in length and weigh over 220kg, making them the largest tortoises in the world. This miraculous species can survive over a year without food or water, able to store tremendous volumes of liquid in their bladders in periods of drought - one of the many adaptive characteristics that enable them to routinely live well over 150-years-old. Darwin notably observed the species’ two unique primary shell morphologies - saddleback and domed. Some subspecies, such as the Pinta Island Tortoise ( Chelonoidis niger abingdonii ), have saddle-shaped shells which raise at the front, making it easier for the neck to stretch upwards to feed on taller vegetation on hotter, more arid islands. Whereas the populations with the dome-shaped shells, including the Chelonoidis niger porteri , occupy islands where there’s an abundance of flora lower to the ground, making upward stretching of the neck unnecessary to feed. Features such as these are well documented in Darwin’s evidence for evolutionary adaptation throughout the islands. Torment and tragedy Only two centuries ago, the Galápagos Islands were rife with life, with an estimated 250,000 giant tortoises. Today, multiple species are extinct, with only around 10% of the individuals surviving. The dramatic decline of the Galápagos tortoises has been characterised by frequent human failure, and in some instances, human design. Between the 1790s and 1800s, whalers began operating around the Galápagos, routinely taking long voyages to explore the Pacific Ocean. With whaling voyages lasting about a year, the tortoises were selected as the primary source of fresh meat for the whalers, with each taking 200 to 300 tortoises aboard. Here, in a ship’s hold, the hundreds of tortoises would live without food or water for months, before being killed and consumed. Documentation regarding how many tortoises were taken aboard by whalers is scarce, however estimates place the number between 100,000 and 200,000 by 700 whaling ships between 1800 and 1870. This initial decimation via over-consumption was then followed by the introduction of harmful invasive species. In the years since, multiple foreign species have been introduced to the archipelago, mainly for farming, including pigs (a lot of which are feral), dogs, cats, rats, goats and donkeys. These non-native species are an enduring threat to the giant tortoise populations, preying on their eggs and hatchings, whilst also providing fierce and unprecedented competition for food. Furthermore, increasing temperatures attributed to climate change are thought to trigger atypical migrations. These migrations have the potential to reduce tortoise nesting success, further adding to the list of threats these species have had to endure. The Pinta giant tortoise, Chelonoidis nigra abingdonii , a species of the unique saddleback shell variety, was thought to be extinct since the early 20th century. But then, in 1971, József Vágvölgyi, a Hungarian scientist on Pinta island made a special discovery – Lonesome George. Seemingly a sole survivor of his kind, Lonesome George became an icon of the sparking conservation movement surrounding the Galápagos species. This lone Pinta individual could have been wandering the small island for decades in search for another member of his species - a search that would unfortunately never bear fruit. Despite selective breeding efforts, on June 24, 2012, at 8:00 A.M. local time, Lonesome George would pass away without producing any offspring, found by park ranger Fausto Llerena who had looked after him for forty years. Hope and the future Despite all the devastation the Galápagos tortoises have endured, not is all lost. Just like the story of Lonesome George, a microcosm of this larger crisis, there is a small light at the end of the tunnel. Just prior to George’s passing a remarkable discovery was made. During 2008, research conducted by the Ecology and Evolutionary Biology Department of Yale University on neighbouring Isabela Island, set out to genetically sequence the local giant tortoise population. Over 1,600 tortoises were tagged and sampled for their DNA, with analyses revealing an astonishing number of tortoises with mixed genetic ancestry. Within this sample, 17 individuals contained DNA from the Pinta tortoise species (and more contained DNA from the also extinct Floreana species). Retrospective study of old whaling logbooks seems to indicate that, in order to lighten the burden of their ships, whalers and pirates dropped large numbers of tortoises in Banks Bay, near Volcano Wolf, Isabela Island, likely accounting for these hybrids. This miracle discovery opens the door to selective breeding efforts, pathing a future of reintroduction of the previously-extinct Pinta Island species. While only a fraction of their original numbers remain, the Galápagos tortoises continue to personify evolution’s stunning intricacies and persist as a bright beacon of hope for the greater world of conservation. It is vital that we do our part as human beings to correct the errors of our past and to respect and nurture these gentle giants and all that they represent in this world we call home. Written by Theo Joe Andreas Emberson Related articles: Conservation of marine iguanas / 55 years of vicuna conservation / Gorongosa National Park REFERENCES Sulloway FJ. Tantalizing tortoises and the Darwin-Galápagos legend. J Hist Biol. 2009;42(1):3-31. doi:10.1007/s10739-008-9173-9 Patrick J. Endres. AlaskaPhotoGraphics.com Project Gallery

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Germline gene therapy (GGT): its potential and problems 05/02/25, 16:33 Last updated: Published: 21/01/24, 11:47 A Scientia News Biology and Genetics collaboration Introduction Genetic diseases arise when there are alterations or mutations to genes or genomes. In most acquired cases, mutations occur in somatic cells. However, when these mutations happen in germline cells (i.e. sperm and egg cells), they are incorporated into the genome of every cell. In other words, should this mutation be deleterious, all cells will have this issue. Furthermore, this mutation becomes inheritable. This is partly why most genetic diseases are complicated to treat and cure. Gene therapy is a concept that has been circulating among geneticists for some time. Indeed, addressing a disease directly from the genes that caused or promoted it has been an attractive and appealing avenue of therapies. The first successful attempt at gene therapy dates back to 1990, using retrovirus-derived vectors to transduce the T-lymphocytes of a 4-year-old girl with X-linked severe combined immunodeficiency disease (SCID-X1) with enzyme adenosine deaminase (ADA) deficiency. The trial was a great success, eliminating the girl's disease and marking a great milestone in the history of genetics. Furthermore, the success of viral vectors also opened new avenues to gene editing, such as zinc finger nucleases and the very prominent CRISPR-Cas9. For example, in mid-November 2023, the UK Medicines and Healthcare products Regulatory Agency or MHRA approved the CRISPR-based gene therapy, Casgevy, for sickle cell disease and β-thalassemia. It is clear that the advent of gene therapies significantly shaped the treatment landscape and our approach to genetic disorders. However, for most of gene therapy history, it is done almost exclusively on somatic cells or some stem cells, not germline cells. How it works As mentioned, inherited genetic disease-associated mutations are also present in germline cells or gametes. The current approach to gene therapy targets genes of some or very specific somatic or multipotent stem cells. For example, in the 1990 trial, the ADA-deficient SCID-X1 T-lymphocytes were targeted, and in recently approved Casgevy, the BCL11A erythroid-specific enhancer in hematopoietic stem cells. The methods involved in gene therapies also vary, each with advantages and limitations and carrying some therapeutic risks. Nevertheless, when aiming to treat genetic diseases, gene therapy should answer two things: how to do it and where. There are a few elucidated strategies of gene therapies. Unlike some popular beliefs, gene therapies do not always directly change or edit mutated genes. Instead, some gene therapies target enhancers or regulatory regions that control the expression of mutated genes. In other cases, such as in Casgevy, enhancers of a different subtype are targeted. By targeting or reducing BCL11A expression, Casgevy aims to induce the production of foetal haemoglobin (HbF), which contains the γ-globin chain as opposed to the defective β-chain in the adult haemoglobin (HbA) of sickle cell disease or β-thalassemia. Some gene therapies can also be done ex vivo or in vivo . Ex vivo strategies involve extracting cells from the body and modifying them in the lab, whilst in vivo strategies directly modify the cell without extraction (e.g. using viral/ non-viral vectors to insert genes). In essence, the list of strategies for gene therapies is growing, each with limitations and a promising prospect of tackling genetic diseases. These methods aim to “cure” genetic diseases in patients. However, the strategies mentioned above have all been researched using and, perhaps, made therapeutically for somatic or multipotent stem cells. Germline gene therapy (GGT), involves directly editing the genetic materials of germline cells or the egg and sperm cells before fertilisation. This means if it is done successfully, fertilisation of these cells will eliminate the disease phenotype from all cells of the offspring instead of only effector cells. Potentially, GGT may eradicate a genetic disease for all future generations. Therefore, it is an appealing alternative to human embryo editing, as it achieves similar or the same result without the need to modify an embryo. However, due to its nature, its advantage may also be its limitation. Ethical issues GGT has the potential to cure genetic disorders within families. However, because it involves editing either the egg or sperm cells before fertilisation, there are prominent ethical issues associated with this method, like the use of embryos for research and many more. Firstly, GGT gives no room for error. Mistakes during the gene modification process could cause systemic side effects or a harsher disease than the one initially targeted, leading to a multigenerational effect. For example, if parents went to a clinic to check if one/both their germ cells have a gene coding for proteins implicated in cystic fibrosis, an off-target mistake during GGT may lead to their child developing Prader-Willi Syndrome or other hereditary disorders caused by editing out significant genes for development. Secondly, an ecological perspective asserts that the current human gene pool, an outcome of many generations of natural selection, could be weakened by germline gene editing. Also, there is the religious perspective, where editing embryos goes against the natural order of how god created living creatures as they should be, where their natural phenotypes are “assigned” for when they are alive. Another reason GGT may be unethical is it leads to eugenics or creating “designer babies”. These are controversial ideas dating back to the late 19th century, where certain traits are “better” than others. This implies they should appear in human populations while individuals without them should be sterilised/killed off. For instance, it is inconceivable to forget the Nazi Aktion T4 program, which sought to murder disabled people because they were seen as “less suitable” for society. Legal and social issues Eugenics is notorious today because of its history. Genetic counselling may be seen like this as one possible outcome may be parents who end pregnancies if their child inherits a genetic disease. Moreover, understanding GGT’s societal influences is crucial, so clinical trial designs must consider privacy, self-ownership, informed consent and social justice. In China, the public’s emotional response to GGT in 2018 was mainly neutral, as shown in Figure 1, but some of the common “hot words” when discussed were ‘mankind’, ‘ethics’, and ‘law’. With this said, regulations are required with other nations for a wider social consensus on GGT research. In other countries, there are stricter rules for GGT. it is harder to conduct experiments using purposely formed/altered human embryos with inheritable mutations in the United States because the legal outcomes can include prison time and $100,000 fines. Furthermore, when donors are required, they must be fairly compensated, and discussing methodologies is crucial because there are issues on how they can impact men and women. South Africa has two opposing thoughts on GGT or gene editing. Bioconservatism has worries about genetic modification and asserts its restrictions, while bioliberalism is receptive to this technology because of the possible benefits. Likewise, revisions to the current regulations are suggested, such as rethinking GGT research or a benefit-risk analysis for the forthcoming human. Conclusion Overall, gene therapies have transformed the therapeutic landscape for genetic diseases. GGT is nevertheless a unique approach that promises to completely cure a genetic disease for families without the need to edit human embryos. However, GGT’s prospects may do more harm than good because its therapeutic effects are translated systemically and multigenerationally. On top of that, controversial ideas such as designer babies can arise if GGT is pushed too far. Additionally, certain countries have varying regulations due to cultural attitudes towards particular scientific innovations and the beginning of life. Reflecting on the ethical, legal and social issues, GGT is still contentious and probably would not be a prominent treatment option anytime soon for genetic diseases. Written by Sam Jarada and Stephanus Steven Introduction, and How it works by Stephanus Ethical issues, and Legal and social issues by Sam Conclusion by Sam and Stephanus Related article: Monkey see, monkey clone References: Cavazzana-Calvo, M. et al. (2000) ‘Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease’, Science , 288(5466), pp. 669–672. doi:10.1126/science.288.5466.669. Demarest, T.G. and Biferi, M.G. (2022) ‘Translation of gene therapy strategies for amyotrophic lateral sclerosis’, Trends in Molecular Medicine , 28(9), pp. 795–796. doi:10.1016/j.molmed.2022.07.001. Frangoul, H. et al. (2021) ‘CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia’, New England Journal of Medicine , 384(3), pp. 252–260. doi:10.1056/nejmoa2031054. AGAR, N. (2018). Why We Should Defend Gene Editing as Eugenics. Cambridge Quarterly of Healthcare Ethics, 28(1), pp.9–19. doi: https://doi.org/10.1017/s0963180118000336 . de Miguel Beriain, I., Payán Ellacuria, E. and Sanz, B. (2023). Germline Gene Editing: The Gender Issues. Cambridge Quarterly of Healthcare Ethics, 32(2), pp.1–7. doi: https://doi.org/10.1017/s0963180122000639 . Genome.gov . (2021). Eugenics: Its Origin and Development (1883 - Present). [online] Available at: https://www.genome.gov/about-genomics/educational-resources/timelines/eugenics#:~:text=Discussions%20of%20eugenics%20began%20in . Johnston, J. (2020). Budgets versus Bans: How U.S. Law Restricts Germline Gene Editing. Hastings Center Report, 50(2), pp.4–5. doi: https://doi.org/10.1002/hast.1094 . Kozaric, A., Mehinovic, L., Stomornjak-Vukadin, M., Kurtovic-Basic, I., Catibusic, F., Kozaric, M., Mesihovic-Dinarevic, S., Hasanhodzic, M. and Glamuzina, D. (2016). Diagnostics of common microdeletion syndromes using fluorescence in situ hybridization: single center experience in a developing country. Bosnian Journal of Basic Medical Sciences, [online] 16(2). doi: https://doi.org/10.17305/bjbms.2016.994 . Luque Bernal, R.M. and Buitrago BejaranoR.J. (2018). Assessoria genética: uma prática que estimula a eugenia? Revista Ciencias de la Salud, 16(1), p.10. doi: https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.6475 . Nielsen, T.O. (1997). Human Germline Gene Therapy. McGill Journal of Medicine, 3(2). doi: https://doi.org/10.26443/mjm.v3i2.546 . Niemiec, E. and Howard, H.C. (2020). Germline Genome Editing Research: What Are Gamete Donors (Not) Informed About in Consent Forms? The CRISPR Journal, 3(1), pp.52–63. doi: https://doi.org/10.1089/crispr.2019.0043 . Peng, Y., Lv, J., Ding, L., Gong, X. and Zhou, Q. (2022). Responsible governance of human germline genome editing in China. Biology of Reproduction, 107(1). doi: https://doi.org/10.1093/biolre/ioac114 . Shozi, B. (2020). A critical review of the ethical and legal issues in human germline gene editing: Considering human rights and a call for an African perspective. South African Journal of Bioethics and Law, 13(1), p.62. doi: https://doi.org/10.7196/sajbl.2020.v13i1.00709 . Thaldar, D., Botes, M., Shozi, B., Townsend, B. and Kinderlerer, J. (2020). Human germline editing: Legal-ethical guidelines for South Africa. South African Journal of Science, 116(9/10). doi: https://doi.org/10.17159/sajs.2020/6760 . Zhang, D. and Lie, R.K. (2018). Ethical issues in human germline gene editing: a perspective from China. Monash Bioethics Review, 36(1-4), pp.23–35. doi: https://doi.org/10.1007/s40592-018-0091-0 . Project Gallery

Common questions and answers- along with helpful resources- regarding the International Baccalaureate programme. International Baccalaureate (IB) Are you a student currently studying the IB, or about to commence your IB program? You're in the right place! You may also like: A-level resources , University prep and Extra resources What is the IB? Jump to resources It is an International Academic Program which is another alternative to A levels. This is a highly academic program with final exams that prepare students for university and careers. You select one subject from each of the five categories, which include two languages, social sciences, experimental sciences, and mathematics. You must also choose either an arts subject from the sixth group or another from the first to fifth groups. How is the IB graded? Subjects might differ from schools and countries but these are the ideal subjects given in the IB. IB is graded through a point system (7 being the highest and 1 being the lowest) and the highest mark you can achieve in total is 45. For the 6 subjects you study you can achieve a maximum of 42 points. Theory of Knowledge and Extended Essay are combined to gain 3 extra bonus points. These 2 subjects will be marked from A (highest) to E (lowest) and then will be converted to points. What are the benefits of studying the IB? Even though there are a lot of subjects, this programme is great for students to gain new skills and be an all- rounder. IB also helps students to have a better idea of how work will be in university especially with coursework and that is one of the main things you will work on when studying IB- it is known as Internal Asssessment (IA). Doing CAS is also a great opportunity for students to be independent and find activities/ services to do outside of school to build up their portfolio on CAS as well as their CV/ personal statement when applying for university. The marking matrix used in the IB. How do universities use the IB to select students? All universities around the world accept the IB as a qualification gained in secondary school. Depending on the degree you are applying to, universities mainly focus on your Higher Level (HL) subjects. Each university has their own requirements for students applying to study a course at their institution. The most common way is considering your total point score out of 45, and your total point score of your HL subjects. Another way is asking applicants to achieve a certain grade in a particular grade at HL or at standard level (SL). If you complete the IB programme well enough, universities may prefer you over the other qualifications e.g. A-levels. Benefits of completing the IB programme. Resources for revision Websites to help Official IB website and the IB Bookshop Maths IA ideas Maths Analysis and Approaches SL and HL practice questions Maths resources in general / Worksheets and more Biology- BioNinja Biology, Chemistry, Physics, Maths- Revision Village / Save My Exams Biology, Chemistry, Maths- IB Dead IB Psychology IB Computer Science resources YouTube channels to help Chemistry- Richard Thornley Physics- Chris Doner Textbooks for both HL and SL Bio: Oxford IB Diploma Programme: Biology Course Biology for the IB Diploma by Brenda Walpole Chem: Chemistry Oxford IB Diploma Programme: Chemistry Course Chemistry for the IB Diploma Coursebook with Cambridge Elevate Enhanced Edition b y Steve Owen Physics: Physics Oxford IB Diploma Programme: Physics Course Physics for the IB Diploma with Cambridge by T. A. Tsokos Maths: Maths Oxford IB Diploma Programme- IB Mathematics: analysis and approaches / applications and interpretations

The researchers counted over 100,000 neurons and over a billion connections between them within this small cube of brain tissue. To find all the neurons and reconstruct the neural network, researchers had to slice the mouse brain 25,000 times. The issue is Go back Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Can a human brain be linked to a computer? Last updated: 06/11/24 Published: 28/12/22 Scientists in the US have succeeded in mapping the three-dimensional structure of the network of neurons in one cubic millimetre of mouse brain- a feat that would require two petabytes of storage. The human brain contains approximately 100 billion neurons, which is one million times the number of neurons found in a cubic millimetre of mouse brain. The researchers counted over 100,000 neurons and over a billion connections between them within this small cube of brain tissue. To find all the neurons and reconstruct the neural network, researchers had to slice the mouse brain 25,000 times. The issue is that the amount of data to store would kill any single computer. Memory and experiences that would have defined people later would be lost if they tried to store their minds too early. Using a computer too late may result in the accumulation of a mind with dementia, which would not work so well. Human tissue would have to be cut into zillions of thin slices using techniques compatible with dying and cutting. Local electrical changes that travel down dendrites and axons allow neurons to communicate with one another. However, when reconstructing the 3D structure, this may not be possible. After we die, our brains undergo significant chemical and anatomical changes. At the age of 20, they begin to lose 85,000 neurons per day due to apoptosis, or programmed cell death. Many memories that would have shaped a person later would be lost if he or she tried to store their mind too early. There are numerous steps involved in developing a computer capable of storing and processing human-level intelligence. It may be impossible for an artificial intelligence to produce sensations and actions identical to those provided and produced by your biological body. Bots are susceptible to hacking and hardware failure. Connecting sensors to the AI's digital mind would also be difficult. Written by Jeevana Thavarajah Related articles: The evolution of AI / The wonders of the human brain / AI in genetic diagnoses

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link NGAL: A Valuable Biomarker for Early Detection of Renal Damage 24/09/24, 11:10 Last updated: Published: 04/04/24, 16:20 How kidney damage can be detected Nestled under the ribcage, the kidneys are primarily responsible for the filtration of toxins from the bloodstream and their elimination in urine. In instances of Acute Kidney Injury (AKI), however, this vital function is compromised. AKI is the sudden loss of kidney function, which is commonly seen in hospitalised patients. Because patients don’t usually experience pain or distinct symptoms, AKI is difficult to identify. Early detection of AKI is paramount to prevent kidney damage from progressing into more enduring conditions such as Chronic Kidney Disease (CKD). So, how can we detect AKI promptly? This is where Neutrophil Gelatinase-Associated Lipocalin (NAGL), a promising biomarker for the early detection of renal injury, comes into focus. Until recently, assessing the risk of AKI has relied on measuring changes in serum creatinine (sCr) and urine output. Creatinine is a waste product formed by the muscles. Normally, the kidney filters creatinine and other waste products out of the blood into the urine. Therefore, high serum creatinine levels indicate disruption to kidney function, suggesting AKI. However, a limitation of the sCr test is that it is affected by extrarenal factors such as muscle mass; people with higher muscle mass have higher serum creatinine. Additionally, an increase in this biomarker becomes evident once the renal function is irreversibly damaged. NGAL’s ability to rapidly detect kidney damage hours to days before sCr, renders it a more fitting biomarker to prevent total kidney dysfunction. Among currently proposed biomarkers for AKI, the most notable is NGAL. NGAL is a small protein rapidly induced from the kidney tubule upon insult. It is detected in the bloodstream within hours of renal damage. NGAL levels swiftly rise much before the appearance of other renal markers. Such characteristics render NGAL a promising biomarker in quickly pinpointing kidney damage. The concentration of NGAL present in a patient's urine is determined using a particle-enhanced laboratory technique. This involves quantifying the particles in the solution by measuring the reduced transmitted light intensity through the urine sample. In conclusion, the early detection of AKI remains a critical challenge, but NGAL emerges as a promising biomarker for promptly detecting renal injury before total loss of kidney function unfolds. NGAL offers a significant advantage over traditional biomarkers like serum creatinine- its swift induction upon kidney injury allows clinicians and healthcare providers to intervene before renal dysfunction manifests. Written by Fozia Hassan Related article: Cancer biomarkers and evolution REFERENCES Bioporto. (n.d.). NGAL . [online] Available at: https://bioporto.us/ngal/ [Accessed 5 Feb. 2024]. Branislava Medić, Branislav Rovčanin, Katarina Savić Vujović, Obradović, D., Duric, D. and Milica Prostran (2016). Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations. Current Medicinal Chemistry , [online] 23(19). doi: https://doi.org/10.2174/0929867323666160210130256 . Buonafine, M., Martinez-Martinez, E. and Jaisser, F. (2018). More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clinical Science , [online] 132(9), pp.909–923. doi: https://doi.org/10.1042/cs20171592 . Giasson, J., Hua Li, G. and Chen, Y. (2011). Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases. Inflammation & Allergy - Drug Targets , [online] 10(4), pp.272–282. doi: https://doi.org/10.2174/187152811796117753 . Haase, M., Devarajan, P., Haase-Fielitz, A., Bellomo, R., Cruz, D.N., Wagener, G., Krawczeski, C.D., Koyner, J.L., Murray, P., Zappitelli, M., Goldstein, S.L., Makris, K., Ronco, C., Martensson, J., Martling, C.-R., Venge, P., Siew, E., Ware, L.B., Ikizler, T.A. and Mertens, P.R. (2011). The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury. Journal of the American College of Cardiology , [online] 57(17), pp.1752–1761. doi: https://doi.org/10.1016/j.jacc.2010.11.051 . Moon, J.H., Yoo, K.H. and Yim, H.E. (2020). Urinary Neutrophil Gelatinase – Associated Lipocalin: A Marker of Urinary Tract Infection Among Febrile Children. Clinical and Experimental Pediatrics . doi: https://doi.org/10.3345/cep.2020.01130 . Vijaya Marakala (2022). Neutrophil gelatinase-associated lipocalin (NGAL) in kidney injury – A systematic review. International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine , [online] 536, pp.135–141. doi: https://doi.org/10.1016/j.cca.2022.08.029 . www.nice.org.uk . (2014). Overview | The NGAL Test for early diagnosis of acute kidney injury | Advice | NICE . [online] Available at: https://www.nice.org.uk/advice/mib3 [Accessed 6 Feb. 2024]. Project Gallery

Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Artificial intelligence in space 21/11/24, 12:08 Last updated: Published: 19/11/23, 17:31 AI in developing space technologies Artificial intelligence or AI has become an important force or a tool that drives the evolution of technologies that improve human life and helps unlock the secrets of the universe beyond the influence of our planet. In simple words, AI is something that enables a computer/ robot to mimic human intelligence and it is revolutionizing the way we explore and utilize space, enhancing everything from spacecraft navigation and autonomous decision-making to data analysis and mission planning. This article explores the profound impact of AI in the development of space related technologies. Mission planning and design Space mission planning and payload, instrument designs rely on the gathered previous mission data. However, access to all the historic mission data is only provided to individuals with a higher authority access at the space agency which requires a lot of paper works and approvals. But recently NASA came up with a solution and they named it as the “Data Acquisition Processing and Handling Network Environment” (DAPHNE) system. Daphne is an AI assistant which can access millions of previous mission data including the most restricted ones and provide the scientists an insight about their mission without the need of a higher authority access or security clearance. It can also compute and analyze countless input variables to determine the most efficient routes and schedules for missions, which is crucial for long-duration missions or missions with multiple objectives. Manufacturing Manufacturing processes usually involves complex tasks that requires high precision and attention to detail when it comes to space related applications. The use of AI in spacecraft manufacturing not only accelerates production but also increases precision and reliability. Ai assistants like collaborative bots (cobots) interacts with the engineers and help them to make the right decisions, reduce the overall assembly process time and also provide insights about the final product which ensures that the spacecrafts are built to the highest standards. Data processing Space missions generate vast amounts of data, from images and telemetry to instrument readings. AI algorithms are capable in sifting through this data, identifying patterns, and extracting meaningful insights. An example is the estimation of planetary wind speed which requires a combination of the satellite imagery and meteorological data. AI tools can rapidly analyze these large datasets and help scientists in understanding these planetary phenomena and easily uncover its secrets. This capability is also valuable in missions to study distant galaxies, black holes, and exoplanets. Navigation & guidance systems One of the critical applications of AI in space technology is autonomous navigation. Spacecraft traveling vast distances through the cosmos must constantly adjust their trajectories to avoid collisions with celestial bodies and maximize their fuel efficiency. Advanced AI systems can process data in real-time and autonomously adjust a spacecraft's course. This not only reduces the need for constant human intervention from the ground station but also allows for more precise and efficient missions. Astronaut health monitoring Astronauts in space face a range of health issues like bone density loss, cardiovascular issues etc. The AI systems can continuously monitor physiological data and provide an insight into the astronaut’s health condition including sleep patterns. This allows early detection of health issues and timely intervention which reduces the need for immediate communication with ground mission control, ultimately safeguard the safety of the astronauts on long-duration missions. In summary, AI is a tool that represents a transformative shift in how we explore and understand our cosmos and its secrets. One day AI will play an even more significant role in the future that pushes the boundaries of space and bring us closer to answering some of humanity’s most profound questions. Written by Arun Sreeraj Related articles: Astronauts in space / AI in drug discovery / Evolution of AI / Chemistry in space exploration Project Gallery